According to Genetic Technologies latest financial reports the cash on hand of GTG is $5.33M, an decrease of -33.07% to 2022. At the end of 2022 company had $7.96M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $5.33M | -33.07% |
2022 | $7.96M | -43.88% |
2021 | $14.19M | 47.05% |
2020 | $9.65M | 550.47% |
2019 | $1.48M | - |